Coretherapix Overview

  • Founded
  • 2006

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Coretherapix General Information

Description

Manufacturer of pharmaceutical products. The company engages in manufacturing of AlloCSC-01 and regenerative therapies to stimulate the endogenous repair of the heart, and to prevent the negative consequences of myocardial infarction.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Santiago Grisolía, 2
  • Tres Cantos
  • 28760 Madrid
  • Spain

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Coretherapix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Coretherapix‘s full profile, request access.

Request a free trial

Coretherapix Patents

Coretherapix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2019076112-A Adult cardiac stem cell population Pending 15-Mar-2013 000000000
US-20160030485-A1 Adult cardiac stem cell population Active 15-Mar-2013 000000000
US-20140271575-A1 Adult cardiac stem cell population Inactive 15-Mar-2013 0000000000 0
AU-2014229176-B2 Adult cardiac stem cell population Active 15-Mar-2013 000000000
CA-2907043-A1 Adult cardiac stem cell population Active 15-Mar-2013 A61K35/34
To view Coretherapix’s complete patent history, request access »

Coretherapix Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Coretherapix‘s full profile, request access.

Request a free trial